Savings Page Header


PRESTIUM PRESCRIPTION SAVINGS PROGRAM

With Prestium Pharma's Prescription Savings Program, your patients can save up to $45 off out-of-pocket costs each time their pharmacist fills or refills the prescription. Ask for a supply of Prescription Savings Cards to provide your patients with their script.


The cards are valid at participating pharmacies for one use per medicine per month. Not valid for patients under Medicaid, Medicare (including Medicare Part D), or similar state or federal programs. The card is not valid for residents of Massachusetts unless the patient is paying the full cost of the prescription.


How the Prestium Pharma Combo Savings Card Works for Your Patients:

 

  • Pay the initial $15, you could recieve up to $45 off your co-pay or out-of-pocket expenses.

  • You may pay more than $15 if your co-pay exceeds $60; if your insurance does not cover Denavir, Elimite, Evoclin, Extina, Luxiq, Olux, Olux-E or Vusion; or if you are a chase payer.

  • Go to www.PrestiumPharma.com for more information.

  • For assistance with the Prestium Pharma Combo Savings Card, contact 1-855-820-3232.

  • After each transaction, keep this card for up to 12 total uses.

 


IMPORTANT SAFETY INFORMATION


Full Prescribing Information


  • EVOCLIN® (clindamycin phosphate) Foam, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, or a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis, including pseudomembranous colitis.

  • Prescribe with caution in atopic individuals.

  • Concomitant topical acne therapy should be used with caution since a possible cumulative irritancy may occur, especially with the use of peeling, desquamating, or abrasive agents. If irritation or dermatitis occurs, EVOCLIN Foam should be discontinued.

  • Diarrhea, bloody diarrhea, and pseudomembranous colitis have been reported with systemic and rarely with topical clindamycin. Discontinuation is recommended if significant diarrhea develops.

  • In clinical trials, the most common adverse events were headache (3%) and application-site reactions, including burning (6%), itching (1%), and dryness (1%).

  • The contents of EVOCLIN Foam are flammable; patients should avoid fire, flame, and/or smoking during and immediately following application.








EVOCLIN Foam is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older.

Prestium Prescription
Savings Program